Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,429
Total Claims
$968K
Drug Cost
338
Beneficiaries
$2,863
Cost/Patient
Risk Score Breakdown 45/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+503%
Opioid rate vs peers
55.4% vs 9.2% avg
+298%
Cost per patient vs peers
$2,863 vs $719 avg
+99%
Brand preference vs peers
13.3% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 503% above the average for Physician Assistant providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
55.4%
Opioid Rate
3,560
Opioid Claims
$333K
Opioid Cost
22.5%
Long-Acting Rate
This provider's opioid prescribing rate of 55.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 852 claims · $723K
Generic: 5,577 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Methylnaltrexone Bromide | 57 | $143K |
| Rimegepant Sulfate | 64 | $132K |
| Oxycodone Myristate | 76 | $58K |
| Buprenorphine Hcl | 57 | $53K |
| Oxycodone Hcl | 64 | $48K |
| Erenumab-Aooe | 54 | $43K |
| Gabapentin Enacarbil | 38 | $38K |
| Hydrocodone/Acetaminophen | 1,114 | $33K |
| Atogepant | 28 | $32K |
| Buprenorphine Hcl/Naloxone Hcl | 142 | $29K |
| Naldemedine Tosylate | 46 | $22K |
| Ubrogepant | 12 | $21K |
| Tapentadol Hcl | 16 | $19K |
| Oxycodone Hcl/Acetaminophen | 638 | $19K |
| Hydrocodone Bitartrate | 42 | $17K |
Prescribing Profile
62
Unique Drugs
45.0
Anomaly Score
Patient Profile
69
Avg Age
69%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About